Physician profile
Simon Pedro Jacquez
NPI 1336820976
$1,039.93
in general payments reported to CMS, 2019-2025
10 companies · $782 in 2025
The $782 reported for 2025 was more than what 76% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $118 · 2024: $140 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,039.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $234.52 | 2023-2025 | Watchman Flx |
| Medtronic, INC. | $171.20 | 2025 | Closurefast |
| Exact Sciences Corporation | $149.14 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Intuitive Surgical, INC. | $127.29 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $118.65 | 2024 | Farxiga |
| Edwards Lifesciences Corporation | $100.95 | 2025 | Sapien 3 Ultra Resilia |
| Abiomed | $76.47 | 2025 | |
| Globus Medical, INC. | $21.74 | 2025 | Senza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.50 | 2024 | Lifevest |
| Merck Sharp & Dohme LLC | $18.47 | 2023 | Vaxneuvance, Gardasil 9, Rotateq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Jacquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.